MiR-491-5p has been reported to efficiently induce apoptosis in ovarian carcinoma by targeting BCL2L1 and accumulating BCL2L11 in its dephosphorylated form.37 In pancreatic cancer, miR-491-5p expression was decreased compared with normal tissue. Here, BCL2L1 is linked to ovarian carcinoma.